Module Innovations
Module Innovations is a company focused on precision diagnostics at the point of care, leveraging nanotechnology and biotechnology to develop rapid diagnostic solutions for infectious diseases and antimicrobial resistance. They aim to revolutionize UTI management and treatment across healthcare settings, emphasizing patient care at the point of care.
Industries
Nr. of Employees
small (1-50)
Module Innovations
Patents
Products
Rapid point-of-care UTI diagnostic test
A diagnostic assay designed to provide a UTI positive/negative result at the point of care with an approximately 15-minute turnaround.
Rapid antimicrobial susceptibility test for uropathogens
A rapid AST workflow intended to provide antimicrobial susceptibility profiling of uropathogens within a short timeframe (reported examples around 2 hours) to support targeted therapy.
SDSAN
Patented platform technology for ultra-rapid diagnostics for infectious diseases and antimicrobial resistance (AMR), designed to deliver rapid and accurate diagnostics for clinicians.
Rapid point-of-care UTI diagnostic test
A diagnostic assay designed to provide a UTI positive/negative result at the point of care with an approximately 15-minute turnaround.
Rapid antimicrobial susceptibility test for uropathogens
A rapid AST workflow intended to provide antimicrobial susceptibility profiling of uropathogens within a short timeframe (reported examples around 2 hours) to support targeted therapy.
SDSAN
Patented platform technology for ultra-rapid diagnostics for infectious diseases and antimicrobial resistance (AMR), designed to deliver rapid and accurate diagnostics for clinicians.
Services
R&D and product development of rapid diagnostic solutions for urinary tract infections and antimicrobial susceptibility to enable point-of-care decision making.
R&D and product development of rapid diagnostic solutions for urinary tract infections and antimicrobial susceptibility to enable point-of-care decision making.
Expertise Areas
- Point-of-care diagnostics
- Infectious disease diagnostic development
- Antimicrobial susceptibility testing (AMR diagnostics)
- Nanotechnology-enabled sensors and assays
Key Technologies
- Nanotechnology-enabled sensing
- Biotechnology-based diagnostic assays
- Rapid phenotypic antimicrobial susceptibility testing
- Point-of-care diagnostic platforms
News & Updates
Module Innovations became the first Asian diagnostic company to receive CARB-X funding to develop a simple test for urinary tract infections and superbugs within 2 hours.
Recognition as the best startup at ISBACON 2019.
Received the BIRAC NESTA Award for innovation.
Awarded the NBEC Biocon Award for their contributions.
Module Innovations became the first Asian diagnostic company to receive CARB-X funding to develop a simple test for urinary tract infections and superbugs within 2 hours.
Recognition as the best startup at ISBACON 2019.
Received the BIRAC NESTA Award for innovation.
Awarded the NBEC Biocon Award for their contributions.